Rome, June 12, 2025
Math Biology took part in a special session of the Master in Business Management at LUISS Business School, offering students an insider look into how the company is transforming early diagnostics through science, data, and AI.
Held in the heart of Rome, the lecture brought students face-to-face with the founders of Math Biology, who walked them through the company’s journey — from a bold research concept to a rapidly growing startup with international recognition.
The spotlight was on Deep Metabolic-Processes Assessment (DMA®), Math Biology’s AI-native, zero-invasive diagnostic platform. By leveraging data from over 20,000 people, the company has built a model capable of identifying root causes, accelerating diagnoses, and personalizing treatments.
The session explored key topics including:
- Bridging clinical research and entrepreneurship
- Overcoming challenges in the healthcare innovation space
- Building credibility through data and real-world validation
- Designing a community-centered model in digital health
Students were particularly engaged during the Q&A, with questions ranging from the validation process to how Math Biology integrates AI ethically and effectively in healthcare pathways.
“Bringing together biology, mathematics, and AI to serve patients in real-world scenarios is exactly the kind of innovation our students need to see firsthand,” said one of the program’s coordinators.
Key Takeaway:
Math Biology’s presence at LUISS Business School reaffirmed the importance of cross-disciplinary innovation and marked another step in building a new culture of health, rooted in data, prevention, and personalized care — starting from Rome, and growing globally.This isn’t just a test. It’s a new way of living your health journey.